Home » Topics » Briefs » Other news to note

Other news to note
RSS

Novartis to take full ownership of Alcon

Dec. 15, 2010

Anaphore and Mitsubishi Tanabe Pharma to develop protein therapies for autoimmune disorders

Dec. 15, 2010

Infinity Pharma and Mundipharma extend alliance

Dec. 14, 2010

Cephalon and Mesoblast join to develop mesenchymal precursor stem cell therapies

Dec. 10, 2010

Radient Pharma and Jaiva Technologies form NuVax Therapeutics

Dec. 10, 2010

LFB Biotechnologies completes acquisition of GTC Biotherapeutics

Dec. 9, 2010

Insmed and Transave enter into business combination

Dec. 7, 2010

AMT and Amgen amend licencing agreement for GDNF gene therapies

Dec. 3, 2010

Hana Biosciences becomes Talon Therapeutics

Dec. 3, 2010

Symphogen receives milestone payment for antibody therapeutic

Dec. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...